These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21429066)

  • 1. Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy.
    Yehia BR; Fleishman JA; Wilson L; Hicks PL; Gborkorquellie TT; Gebo KA;
    HIV Med; 2011 Oct; 12(9):535-43. PubMed ID: 21429066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era.
    Burkey MD; Wilson LE; Moore RD; Lucas GM; Francis J; Gebo KA
    HIV Med; 2008 Nov; 9(10):858-62. PubMed ID: 18754806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing trends of bacteraemia among HIV-infected Ugandan adults: incidence, aetiology, clinical outcomes and effect of antiretroviral therapy in a semi-urban setting (2000-2008).
    Muyanja SZ; Larke N; Rutebarika D; Kaddu I; Nakubulwa S; Levin J; Grosskurth H; Miiro G
    Trop Med Int Health; 2011 Jun; 16(6):756-65. PubMed ID: 21392188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort.
    Gebo KA; Burkey MD; Lucas GM; Moore RD; Wilson LE
    J Acquir Immune Defic Syndr; 2006 Dec; 43(4):426-32. PubMed ID: 17099314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
    Gebo KA; Diener-West M; Moore RD
    J Acquir Immune Defic Syndr; 2003 Oct; 34(2):165-73. PubMed ID: 14526205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics.
    Meynard JL; Guiguet M; Fonquernie L; Lefebvre B; Lalande V; Honore I; Meyohas MC; Girard PM
    HIV Med; 2003 Apr; 4(2):127-32. PubMed ID: 12702133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors for invasive pneumococcal disease in HIV-positive individuals in the era of highly active antiretroviral therapy.
    Sadlier C; O'Connell S; Kelleher M; Bergin C
    Int J STD AIDS; 2019 Apr; 30(5):472-478. PubMed ID: 30999829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.
    Jones N; Huebner R; Khoosal M; Crewe-Brown H; Klugman K
    AIDS; 1998 Nov; 12(16):2177-84. PubMed ID: 9833859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts.
    McGowan CC; Weinstein DD; Samenow CP; Stinnette SE; Barkanic G; Rebeiro PF; Sterling TR; Moore RD; Hulgan T
    PLoS One; 2011 Apr; 6(4):e18462. PubMed ID: 21541016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.
    Gebo KA; Diener-West M; Moore RD
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):143-52. PubMed ID: 11404536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
    Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.
    Rasmussen LD; Engsig FN; Christensen H; Gerstoft J; Kronborg G; Pedersen C; Obel N
    AIDS; 2011 Aug; 25(13):1637-46. PubMed ID: 21646903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.
    Fu TC; Westergaard RP; Lau B; Celentano DD; Vlahov D; Mehta SH; Kirk GD
    AIDS; 2012 Nov; 26(18):2383-91. PubMed ID: 23079804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in HIV testing, prevalence among first-time testers, and incidence in most-at-risk populations in Spain: the EPI-VIH Study, 2000 to 2009.
    Diez M; Bleda MJ; Varela JR; Ordonana J; Azpiri MA; Vall M; Santos C; Viloria L; de Armas C; Urena JM; Trullen J; Pueyo I; Martinez B; Puerta T; Vera M; Sanz I; Junquera ML; Landa MC; Martinez E; Camara MM; Belda J; Bru FJ; Diaz A;
    Euro Surveill; 2014 Nov; 19(47):20971. PubMed ID: 25443036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe food insecurity is associated with elevated unprotected sex among HIV-seropositive injection drug users independent of HAART use.
    Shannon K; Kerr T; Milloy MJ; Anema A; Zhang R; Montaner JS; Wood E
    AIDS; 2011 Oct; 25(16):2037-42. PubMed ID: 21811140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis-bacteraemia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection.
    Manfredi R; Costigliola P; Ricchi E; Chiodo F
    Clin Ter; 1993 Oct; 143(4):279-90. PubMed ID: 8258261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.
    Gebo KA; Fleishman JA; Moore RD
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):609-16. PubMed ID: 16284539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.
    Himelhoch S; Chander G; Fleishman JA; Hellinger J; Gaist P; Gebo KA
    Gen Hosp Psychiatry; 2007; 29(6):518-25. PubMed ID: 18022045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.